An overview of targeted treatments in cancer
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (8) , 2121-2137
- https://doi.org/10.1016/s0149-2918(03)80209-6
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- Issues on Clinical Applications of Cancer VaccinesJournal of Immunotherapy, 2001
- All-trans-Retinoic Acid in Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1997
- Differentiation Therapy for Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1997
- PML protein expression in hematopoietic and acute promyelocytic leukemia cellsBlood, 1993
- Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1993
- The unique aspects of acute promyelocytic leukemia.Journal of Clinical Oncology, 1990
- Mapping of the human retinoic acid receptor to the q21 band of chromosome 17Human Genetics, 1988
- 15/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIAThe Lancet, 1977